Additional License Fees. (i) U.S. Approval: Two Million Dollars ($2,000,000) payable to Neoprobe upon issuance to Neoprobe of all required regulatory approvals by the FDA for the commercial marketing of a RIGScan System with RIGScan CC49.
Appears in 2 contracts
Sources: License and Distributorship Agreement (Neoprobe Corp), License and Distributorship Agreement (Neoprobe Corp)